Understanding Ozempic for Type 2 Diabetes: Your Weekly Dosing Schedule

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic, works by stimulating insulin release and slowing gastric emptying to help people with type 2 diabetes achieve better blood sugar control. The medication follows a structured weekly injection protocol that typically starts at a low dose and increases over time based on individual tolerance and response. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies, allowing patients to access personalized GLP-1 therapy without insurance requirements.

How Weekly Semaglutide Injections Work for Blood Sugar Control

Semaglutide belongs to a class of medications called GLP-1 receptor agonists, which mimic a natural hormone that regulates blood glucose levels. When you inject semaglutide once per week, it activates GLP-1 receptors throughout your body, triggering your pancreas to release insulin only when blood sugar rises. This targeted approach reduces the risk of dangerously low blood sugar compared to older diabetes medications. The medication also slows how quickly food moves through your stomach, which helps you feel fuller longer and naturally reduces calorie intake.

Clinical trials demonstrate that weekly semaglutide injections lower hemoglobin A1C (a measure of average blood sugar over three months) by approximately 1.5 to 2 percentage points in most patients. This improvement translates to meaningful reductions in diabetes-related complications like kidney damage, nerve damage, and cardiovascular disease. Because semaglutide requires only one injection per week, many patients find it easier to stick with their treatment plan compared to daily oral medications.

Understanding Your Semaglutide Dosing Schedule and Progression

Your semaglutide dosing plan typically begins at 0.25 mg once weekly for the first four weeks to allow your body to adjust to the medication. This low starting dose helps your system tolerate the medication while minimizing side effects like nausea or stomach discomfort. After the first month, your healthcare provider usually increases your dose to 0.5 mg weekly, then continues gradual increases every four weeks as tolerated. Most patients reach a maintenance dose between 1.0 and 2.0 mg weekly, depending on their blood sugar response and how well they tolerate the medication.

The gradual progression schedule serves an important purpose: it allows your body's GLP-1 receptors to become increasingly sensitive to the medication while your digestive system adapts to slower food movement. Skipping doses or jumping to higher doses too quickly often leads to worse side effects without improving results. Your healthcare provider monitors your blood sugar readings and A1C levels throughout this progression to confirm that your dose is working effectively. PlexusDx works with you to ensure your dosing timeline matches your individual health needs and tolerance.

Injection Timing and Administration Best Practices

You inject semaglutide subcutaneously, meaning directly under the skin, once every seven days at approximately the same time each week. Most patients choose a consistent day (such as every Monday morning) to simplify their routine and prevent missed doses. You can inject into your abdomen, thigh, or upper arm, rotating injection sites each week to prevent skin irritation or lipodystrophy (changes in fat distribution under the skin). Each injection takes less than one minute to administer using a pre-filled pen or auto-injector device.

Proper injection technique matters for medication effectiveness and comfort. Keep your semaglutide refrigerated between 36°F and 46°F until you use it; most patients store their weekly pen in the refrigerator and remove it 15 minutes before injecting to allow it to reach room temperature. Always inspect the medication to ensure it remains clear and colorless before injection. If you accidentally miss a dose, inject it as soon as you remember, then resume your regular weekly schedule. Missing a single injection does not significantly impact your blood sugar control.

PlexusDx Compounded Semaglutide: Personalized Dosing Without Insurance Requirements

PlexusDx partners with licensed 503A compounding pharmacies to provide compounded semaglutide injections starting at just $189/mo (or $149/mo on the 6-month plan), flat-rate pricing regardless of your dose strength. This approach eliminates the insurance approval barriers and prior authorization delays that many patients face when accessing brand-name Ozempic. Your dose may need to go up as your treatment progresses—but your price won't increase, giving you predictable monthly costs from start to finish. PlexusDx serves all 50 states with no membership fees, and your treatment qualifies for HSA and FSA reimbursement.

Personalization goes deeper at PlexusDx through the optional Precision Peptide Genetic Test, a peptide-pathway genetic analysis that identifies how your body's specific genetic variants (including GIPR rs1800437, and MC4R rs17782313) influence your response to semaglutide. This test, available for $298, maps 14 metabolic pathways and 150+ genetic insights to help your provider tailor your dose progression and anticipate your likely response. Rather than guessing which dose will work best, PlexusDx uses your genetic blueprint to optimize your treatment from the beginning.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical starting dose of semaglutide for type 2 diabetes?

The standard starting dose is 0.25 mg injected once weekly for the first four weeks. After that initial period, your provider increases the dose to 0.5 mg weekly, then typically continues gradual increases every four weeks until reaching your therapeutic dose between 1.0 and 2.0 mg weekly, depending on your individual response and tolerance.

How does semaglutide improve blood sugar control compared to other diabetes medications?

Semaglutide activates GLP-1 receptors to stimulate insulin release in response to rising blood sugar, while simultaneously slowing stomach emptying and reducing appetite. Clinical trials show semaglutide reduces A1C by 1.5 to 2 percentage points, with added benefits of weight loss and heart disease risk reduction that older medications like metformin or sulfonylureas do not provide.

Can I adjust my semaglutide dose on my own, or does my provider need to manage it?

Your healthcare provider must manage all dose adjustments based on your blood sugar readings and how you tolerate the medication. Increasing your dose too quickly on your own can cause severe nausea and gastrointestinal side effects. PlexusDx providers work with you to establish a safe, personalized dosing schedule and monitor your progress through regular A1C and blood sugar checks.

What are the common side effects when starting semaglutide, and how long do they last?

Nausea, vomiting, diarrhea, and constipation are the most frequent side effects, particularly during the first few weeks of treatment. These effects typically diminish within 4 to 8 weeks as your body adjusts to the medication. Starting at a low dose and progressing gradually significantly reduces the severity of side effects. If side effects become unbearable, your provider can pause dose increases or temporarily reduce your dose.

How does the Precision Peptide Genetic Test help personalize my semaglutide treatment?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Type 2 Diabetes 2
• Ozempic For Type 2 Diabetes
• Zepbound For Type 2 Diabetes
• Glp 1 For Type 2 Diabetes

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.